
OLD Category: immuno-oncology
October 16, 2020 / EMBO Rep
MLLT6 maintains PD‐L1 expression and mediates tumor immune resistance
October 15, 2020 / Transl Oncol
Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression
October 14, 2020 / J Thorac Oncol
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive Non-Small Cell Lung Cancer
October 5, 2020 / Nat Commun